Neuromed

Lublin 20-954

0 studies enrolling now · 2 studies all time

What they study most

Carcinoma, Non-Small-Cell Lung, Relapsing Remitting Multiple Sclerosis

Studies at this site

• THIO Sequenced With Cemiplimab in Advanced NSCLC — Running, not enrolling
• A Phase 2 Study of Orelabrutinib in Patients With Relapsing-Remitting Multiple Sclerosis — Status unconfirmed